“Best Hospitals” add the Total Artificial Heart in their Tool Box

Posted on Thu/19/JulyMon/28/January by AZBio

50% of U.S. News & World Report’s “Best Hospitals” for Cardiology & Heart Surgery Making the Total Artificial Heart Part of Their Toolbox Continue reading→

Genome-wide association studies focus on evolutionary information

Posted on Tue/17/JulyMon/28/January by AZBio

Evolutionary information improves discovery of mutations associated with diseasesContinue reading→

Biochemist awarded ASU’s coveted Galvin Professorship

Posted on Mon/9/JulyMon/28/January by AZBio

An expert in the structural biochemistry and biophysics of membrane proteins, ASU’s Galvin Professor Petra Fromme’s research efforts and multi-institution team are revolutionizing core understanding about infectious disease and creating exciting developments in medicine and clean energy. Continue reading→

Flagship Sails Into New Waters With Expansion Into Neuroscience Pathology Services

Posted on Sun/8/JulyMon/28/January by AZBio

Flagship Biosciencs expands quantitative histopathology services into neurodegenerative disease and neurotoxicity

Stereological and classical image analysis approaches help to more accurately quantify neuropathology and model treatment efficacyContinue reading→

21-Year-Old College Student Literally Dances Her Heart Out

Posted on Thu/7/JuneMon/28/January by AZBio

Dancer Mia Welch Bridged to Heart Transplant with SynCardia Total Artificial HeartContinue reading→

Flagship Biosciences finds Arizona a great home for serving pathology digitally

Posted on Tue/5/JuneMon/28/January by AZBio

Flagship Biosciences, a fast growing pharmaceutical services company based in Flagstaff, AZ, is a leading example of the power of the collaborative nature of the Arizona bioindustry.Continue reading→

Flagship Biosciences expands with acquisition of IHCtech

Posted on Mon/4/JuneMon/28/January by AZBio

Flagship Biosciences acquires IHCtech, a leading provider of research immunohistochemistry and histology services

Combining tissue analysis with expert immunohistochemistry completes Flagship’s novel quantitative pathology approachesContinue reading→

SynCardia Wins 2012 Medical Design Excellence Award

Posted on Thu/31/MayMon/28/January by AZBio

Freedom® Portable Driver for Powering SynCardia’s Total Artificial Heart Honored in Critical Care and Emergency Medicine Category

SynCardia Systems, Inc., the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the company’s Freedom® portable driver, the world’s first wearable power supply for the SynCardia temporary Total Artificial Heart, was selected as the Bronze Winner in the Critical Care and Emergency Medicine category of the 2012 Medical Design Excellence Awards (MDEA) on May 23 in Philadelphia.

“It is an honor to have the premier competition for medical device design and innovation recognize the achievements of our Freedom portable driver,” said Michael Garippa, SynCardia Chairman/CEO/President. “For the first time in U.S. history, the Freedom portable driver is allowing stable patients without human hearts to leave the hospital and resume their lives at home while they wait for a matching donor heart. The Freedom driver is pivotal in the Total Artificial Heart becoming the new standard of care for end-stage biventricular heart failure.”

Weighing 13.5 pounds, the Freedom portable driver is designed to be worn by the patient in the Freedom Backpack or Shoulder Bag. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. More than 80 patients worldwide have been supported by the Freedom driver, accounting for more than 30 patient years of support.

MDEA entries were evaluated on the basis of their design and engineering features, including… read more at SynCardia.com